See the DrugPatentWatch profile for dupixent

Based on the information from DrugPatentWatch.com, Dupixent, a medication used to treat various allergic conditions, experienced significant sales growth from 2019 to 2020. In 2019, Dupixent generated approximately $2.3 billion in revenue [1]. However, by the end of 2020, the drug's sales had more than doubled, reaching an impressive $5.1 billion [1]. This represents a robust year-over-year growth of 121.7%, demonstrating the drug's increasing popularity and clinical success in the market.

Sources:
[1] DrugPatentWatch.com - Dupixent (Dupilumab) - Annual Sales (2017-2021) - <https://www.drugpatentwatch.com/dupixent-dupilumab-annual-sales/>